Company Filing History:
Years Active: 2023
Title: Payel Datta: Innovator in Biosynthetic Heparin
Introduction
Payel Datta is a notable inventor based in Troy, NY (US). She has made significant contributions to the field of biochemistry, particularly in the synthesis of heparin. Her work focuses on creating a biosynthetic version of heparin that is bioequivalent to porcine USP Heparin Sodium.
Latest Patents
Payel Datta holds one patent for her innovative work. The patent pertains to the synthesis of heparin, which involves three intermediates starting from heparosan. This advancement has the potential to improve the availability and safety of heparin for medical use.
Career Highlights
Datta is affiliated with Rensselaer Polytechnic Institute, where she conducts her research and development. Her academic background and research initiatives have positioned her as a key figure in her field.
Collaborations
Some of her notable coworkers include Marc Douaisi and Navdeep Grover. Their collaborative efforts contribute to the advancement of research in biosynthetic materials.
Conclusion
Payel Datta's work in the synthesis of biosynthetic heparin represents a significant advancement in medical science. Her contributions are paving the way for safer and more effective treatments in healthcare.